Ftse Mib
34.219,45
-0,22%
DAX
18.041,75
-0,50%
S&P 500
5.116,17
0,32%
NASDAQ Composite
15.983,08
0,35%
Bitcoin
61.849,59
-3,11%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NYSE Nevro Corp (NVRO) Nevro Corp (NVRO) Notizie

Nevro Corp

NVRO
11,42
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:05:59
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/4/202414:30PRNUSNevro to Report First-Quarter 2024 Financial Results and..
11/3/202421:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202421:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202421:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202421:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202421:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202400:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202422:10PRNUSNevro Receives FDA 510(k) Clearance to Use SI Fixation..
23/2/202423:08EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/2/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:16EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/2/202422:11EDGAR2Form 8-K - Current report
21/2/202422:09EDGAR2Form 8-K - Current report
21/2/202422:06PRNUSNevro Enters Into Cooperation Agreement With Engaged Capital
21/2/202422:05PRNUSNevro Reports Fourth-Quarter and Full-Year 2023 Financial..
14/2/202421:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202421:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/2/202422:30PRNUSNevro Announces Consensus Statement Supporting..
29/1/202422:30PRNUSNevro to Report Fourth-Quarter and Full-Year 2023 Financial..
18/1/202422:15PRNUSNevro Announces Positive Coverage Update from Carelon..
17/1/202422:15PRNUSNevro to Highlight 25 Scientific Abstracts at 2024 North..
11/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
10/1/202423:26EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/1/202414:41EDGAR2Form 8-K - Current report
09/1/202414:30PRNUSNevro Announces Preliminary Fourth-Quarter and Full-Year..
08/1/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:15PRNUSNevro to Present at 42nd Annual J.P. Morgan Healthcare..
03/1/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202315:00EDGAR2Form SC 13D - General statement of acquisition of beneficial..
05/12/202323:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202312:07EDGAR2Form 8-K - Current report
30/11/202323:19PRNUSNevro Announces Acquisition of Vyrsa™ Technologies
30/11/202322:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202322:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202313:00PRNUSNevro Delivers Long-Term Relief with High-Frequency Spinal..
15/11/202300:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202321:57EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202321:07EDGAR2Form 8-K - Current report
01/11/202321:01PRNUSNevro Reports Third Quarter 2023 Financial Results, Provides..
06/10/202323:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202313:00PRNUSNevro to Report Third Quarter 2023 Financial Results
03/10/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202313:00PRNUSNew Data Demonstrate the Health Economic Benefits of Nevro's..
06/9/202323:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202322:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 11,42

La tua Cronologia

NYSE
NVRO
Nevro
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network